PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $209.8M | $194.5M |
| FY2017 | $48.5M | $53.3M | $81.7M |
| FY2018 | $151.9M | $34.3M | $108.4M |
| FY2019 | $95.0M | $17.5M | $60.0M |
| FY2020 | $84.0M | $-6.0M | $85.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $209.8M | $194.5M |
| FY2017 | $48.5M | $53.3M | $81.7M |
| FY2018 | $151.9M | $34.3M | $108.4M |
| FY2019 | $95.0M | $17.5M | $60.0M |
| FY2020 | $84.0M | $-6.0M | $85.3M |